Search For "immunotherapy"
Study reveals why some lung tumours avoid immunotherapy, their advance pre
Updated : 2 years, 11 months ago IST
Immune Checkpoint Blockade, or ICB therapy, has become the gold standard for treating lung cancer because of its frequently successful results. High levels of the PD-L1 protein have served as the main indicator of a favourable response to treatment up until now
Read More
Immunotherapy could be effective for treatment of prostate cancer: Study
Updated : 2 years, 11 months ago IST
According to a study, a novel medication called enoblituzumab, a monoclonal antibody, is safe in men with aggressive prostate cancer and may promote clinical action against cancer across the body.
Read More
Study finds how novel immunotherapy helps fight against high-risk prostat
Updated : 2 years, 11 months ago IST
According to a study, a novel medication called enoblituzumab, a monoclonal antibody, is safe in men with aggressive prostate cancer and may promote clinical action against cancer across the body.
Read More
Study finds biomarker can predict how kidney cancer patients respond to im
Updated : 2 years, 11 months ago IST
According to new research, a biomarker signature can predict how well kidney cancer patients will respond to immunotherapy before treatment even starts. This biomarker signature is made up of the number of immune cells in and around kidney tumours, the volume of dead cancer tissue, and mutat
Read More
Study finds how lymph nodes boost tumor cells after success of immunothera
Updated : 3 years ago IST
According to new research, therapies may cause lymph nodes to produce tumour-fighting T cells.
Read More
Study suggests how immune cell leakage from tumours improve skin cancer tr
Updated : 3 years ago IST
Experiments on mice and human cells reveal that the number of specialised immune cells ready to combat skin cancer increased when a novel therapy prevented their egress from melanoma tumours.
Read More
Research: High-risk bladder patients can benefit from immunotherapy after
Updated : 3 years, 1 month ago IST
According to clinical trial results, immunotherapy after surgery increased bladder cancer patients' chance of staying cancer-free compared to patients who received a placebo.
Read More
Researchers reveal why cancer patients do not react to immunotherapy
Updated : 3 years, 1 month ago IST
Cancer treatment has transformed thanks to immunotherapy. The five-year survival rate for advanced melanoma, the deadliest type of skin cancer, has climbed from less than 10% to more than 50% since the development of immunotherapy in 2011. Sadly, immunotherapy only works on about half of mel
Read More
Cancer patients who do not react to immunotherapy lack crucial immune cell
Updated : 3 years, 1 month ago IST
Immunotherapy has changed cancer treatment. Since the introduction of immunotherapy in 2011, the five-year survival rate in advanced melanoma, the most lethal form of skin cancer, has increased from less than 10% to more than 50%. Unfortunately, only approximately half of melanoma patients r
Read More
Study suggests new type of immunotherapy for ovarian cancer patients
Updated : 3 years, 1 month ago IST
CAR T-cell therapy, a sort of cancer treatment in which the immune system's T cells are trained to attack tumour cells, was found to be effective in mice with ovarian cancer, according to a study.
Read More
Telangana and Flanders to enter a partnership for promoting Lifesciences i
Updated : 3 years, 1 month ago IST
Hyderabad (Telangana) [India], February 11 (ANI/SRV): In continuation with its focus on strengthening its growing stature in the global Lifesciences ecosystem, the Government of Telangana is taking one more step towards forging key global alliances. The government has announced that it is pa
Read More
Researchers reveal how new type of immunotherapy for ovarian cancer
Updated : 3 years, 1 month ago IST
According to a study, CAR T-cell therapy, a type of cancer treatment in which the immune system's T cells are trained to attack tumour cells, is successful in mice with ovarian cancer.
Read More